• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Gender
o Male fertility
o Female Fertility
• Market Segmentation by Service
o Market segments
o Comparison by Service
o Treatment services – Market size and forecast 2019-2024
o Testing and storage services – Market size and forecast 2019-2024
o Other services – Market size and forecast 2019-2024
o Market opportunity by Service
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Anecova SA
o CRITEX GmbH
o Esco Micro Pte. Ltd
o Instituto Bernabeu SL
o INVO Bioscience Inc
o Merck KGaA
o Monash IVF Group Ltd.
o The Cooper Companies Inc.
o Virtus Health Ltd.
o Vitrolife AB
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ billion)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Treatment services – Market size and forecast 2019-2024 ($ billion)
• 22: Treatment services – Year-over-year growth 2019-2024 (%)
• 23: Testing and storage services – Market size and forecast 2019-2024 ($ billion)
• 24: Testing and storage services – Year-over-year growth 2019-2024 (%)
• 25: Other services – Market size and forecast 2019-2024 ($ billion)
• 26: Other services – Year-over-year growth 2019-2024 (%)
• 27: Customer landscape
• 28: Impact of drivers and challenges
• 29: Vendor landscape
• 30: Landscape disruption
• 31: Industry risks
• 32: Vendors covered
• 33: Market positioning of vendors
• 34: Anecova SA – Overview
• 35: Anecova SA – Product and service
• 36: Anecova SA – Key offerings
• 37: Anecova SA – Key customers
• 38: Anecova SA – Segment focus
• 39: CRITEX GmbH – Overview
• 40: CRITEX GmbH – Product and service
• 41: CRITEX GmbH – Key offerings
• 42: CRITEX GmbH – Key customers
• 43: CRITEX GmbH – Segment focus
• 44: Esco Micro Pte. Ltd – Overview
• 45: Esco Micro Pte. Ltd – Product and service
• 46: Esco Micro Pte. Ltd – Key offerings
• 47: Esco Micro Pte. Ltd – Key customers
• 48: Esco Micro Pte. Ltd – Segment focus
• 49: Instituto Bernabeu SL – Overview
• 50: Instituto Bernabeu SL – Product and service
• 51: Instituto Bernabeu SL – Key offerings
• 52: Instituto Bernabeu SL – Key customers
• 53: Instituto Bernabeu SL – Segment focus
• 54: INVO Bioscience Inc – Overview
• 55: INVO Bioscience Inc – Product and service
• 56: INVO Bioscience Inc – Key offerings
• 57: INVO Bioscience Inc – Key customers
• 58: INVO Bioscience Inc – Segment focus
• 59: Merck KGaA – Overview
• 60: Merck KGaA – Business segments
• 61: Merck KGaA – Key offerings
• 62: Merck KGaA – Key customers
• 63: Merck KGaA – Segment focus
• 64: Monash IVF Group Ltd. – Overview
• 65: Monash IVF Group Ltd. – Business segments
• 66: Monash IVF Group Ltd. – Key offerings
• 67: Monash IVF Group Ltd. – Key customers
• 68: Monash IVF Group Ltd. – Segment focus
• 69: The Cooper Companies Inc. – Overview
• 70: The Cooper Companies Inc. – Business segments
• 71: The Cooper Companies Inc. – Key offerings
• 72: The Cooper Companies Inc. – Key customers
• 73: The Cooper Companies Inc. – Segment focus
• 74: Virtus Health Ltd. – Overview
• 75: Virtus Health Ltd. – Business segments
• 76: Virtus Health Ltd. – Key offerings
• 77: Virtus Health Ltd. – Key customers
• 78: Virtus Health Ltd. – Segment focus
• 79: Vitrolife AB – Overview
• 80: Vitrolife AB – Business segments
• 81: Vitrolife AB – Key offerings
• 82: Vitrolife AB – Key customers
• 83: Vitrolife AB – Segment focus
• 84: Currency conversion rates for US$
• 85: Research Methodology
• 86: Validation techniques employed for market sizing
• 87: Information sources
• 88: List of abbreviations
【掲載企業】
Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd, Instituto Bernabeu SL, INVO Bioscience Inc, Merck KGaA, Monash IVF Group Ltd., The Cooper Companies Inc., Virtus Health Ltd., Vitrolife AB
【免責事項】
https://www.marketreport.jp/reports-disclaimer